Research could lead to better understanding of pancreatic cancer

November 9, 2018, University of Surrey
Axial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domain

Surrey's BioProChem group has developed a biomaterial based complex synthetic tissue, which is aimed at replicating the way pancreatic cancer tumours develop within the body.

The research was published in Royal Society of Chemistry Advances in June 2018. It was the result of a three year project led by the BioProChem group within Surrey's Department of Chemical and Process Engineering in collaboration with Imperial College London.

Pancreatic cancer has an extremely low survival rate which has barely improved over the last 40 years. Part of the reason for this is the distinctive microenvironment – the combination of complex chemical, biological, biomechanical and structural factors – found in pancreatic cancer tissues which makes them difficult to treat.

The latest research at Surrey has focused on building a robust polymer-based 3-D structure which mimics features of a and can be tailored to specific tissue properties of individual patients. This could help doctors to understand how a specific tumour would be likely to spread or to respond to treatment, potentially improving outcomes for pancreatic cancer patients.

Dr. Eirini Velliou, who led the research, said: "The scaffold we have created is very robust: it can remain intact in terms of its mechanical qualities and structure for many months. It also mimics biomechanical features of cancer better than many existing lab systems. We have been able to introduce proteins that are present in which effectively create a shell around the tumour and therefore hugely influence the 's resistance to treatment.

"Our next step is to introduce biological complexity into the scaffold by introducing healthy cells into the tumour environment. We are also now working on applying different types of treatment in the 3-D scaffolds such as chemotherapy and novel radiotherapy in collaboration with the Ion Beam Centre, the Royal Surrey County Hospital and the National Physical Laboratory. Ultimately, our platform could enable low-cost patient-specific screening, accelerating therapies from bench to bed."

The full paper is titled "A 3-D bioinspired highly porous polymeric scaffolding system for in vitro simulation of ."

Explore further: Reason for pancreatic cancer's resistance to chemotherapy found

More information: Stella Totti et al. A 3D bioinspired highly porous polymeric scaffolding system for in vitro simulation of pancreatic ductal adenocarcinoma, RSC Advances (2018). DOI: 10.1039/C8RA02633E

Related Stories

Reason for pancreatic cancer's resistance to chemotherapy found

November 21, 2016
A pioneering University of Liverpool research team have published a study that identifies the mechanism in the human body that causes resistance of pancreatic cancer cells to chemotherapy.

New blood test detects early stage pancreatic cancer

September 17, 2018
Pancreatic cancer is currently very difficult to detect while it is still resectable. A new blood test developed by researchers at Lund University in Sweden, Herlev Hospital, Knight Cancer Center and Immunovia AB, can detect ...

New drug blocks pancreatic cancer growth in mice, study finds

September 25, 2018
A newly developed drug can prevent the most common type of pancreatic cancer from growing and spreading in laboratory mice, according to a study led by Cedars-Sinai.

Killer cell immunotherapy offers potential cure for advanced pancreatic cancer

September 4, 2018
A new approach to treating pancreatic cancer using 'educated killer cells' has shown promise, according to a new study by UNSW medical researchers.

Scans could help tailor pancreatic cancer treatment

February 12, 2018
Doctors should use a specialised type of scan to help decide if patients with pancreatic cancer may benefit from surgery, according to the National Institute for Health and Care Excellence (NICE).

Recommended for you

Researchers identify a mechanism that fuels cancer cells' growth

November 14, 2018
Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified sodium glucose transporter 2, or SGLT2, as a mechanism that lung cancer cells can utilize to obtain glucose, which is key to their survival and promotes ...

A new approach to detecting cancer earlier from blood tests: study

November 14, 2018
Cancer scientists led by principal investigator Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have combined "liquid biopsy", epigenetic alterations and machine learning to develop a blood test to detect and classify ...

Photoacoustic imaging may help doctors detect ovarian tumors earlier

November 14, 2018
Ovarian cancer claims the lives of more than 14,000 in the U.S. each year, ranking fifth among cancer deaths in women. A multidisciplinary team at Washington University in St. Louis has found an innovative way to use sound ...

New antibody breakthrough to lead the fight against cancer

November 14, 2018
Scientists at the University of Southampton have developed a new antibody that could hold the key to unlocking cancer's defence against the body's immune system.

Solving the mystery of NPM1 in acute myeloid leukemia

November 13, 2018
Although it has long been recognized that mutations of gene NPM1 play an important role in acute myeloid leukemia, no one has determined how the normal and the mutated forms of the protein NPM1 function.

Cognitive decline—radiation—brain tumor prevented by temporarily shutting down immune response

November 13, 2018
Treating brain tumors comes at a steep cost, especially for children. More than half of patients who endure radiation therapy for these tumors experience irreversible cognitive decline, a side-effect that has particularly ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.